Ascending Dose Pharmacokinetic (PK) and Absolute Bioavailability (BA)
Status:
Completed
Trial end date:
2010-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics of
single rising and multiple rising IV doses of TR-701 FA and to determine the absolute
bioavailability of oral TR-701 FA following single oral and IV dose administrations in
healthy adult subjects.